Forecasting the Potential Market Need for the Injectable Contraceptive, Depot Medroxyprogesterone Acetate (DMPA)
December 2014 - September 2015Overview
WDI is developing a forecast for the demand for the injectable contraceptive depot medroxyprogesterone acetate (DMPA) in predominately low- and middle-income countries. The forecast takes into consideration key factors which are likely to have an impact on demand for DMPA in the future. WDI also assessed the impact of DMPA manufacturers who are likely to be prequalified in the future and enter the market.